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Use and misuse of antimicrobial agents
lead to antimicrobial resistance. This is
well-known, as it is equally well known that
restrictive use results in lower resistance
rates. However, how powerful restrictive
use is in minimizing the rise of antimi-
crobial resistance is not very well docu-
mented.
There are examples in the literature of
changes in antibiotic use that have led
to lowering resistance rates. Well-known
is the drop in erythromycin resistance in
Finland after a policy change with respect
to outpatient treatment of respiratory and
skin infections (1). In Iceland, Kristins-
son et al. showed the relation between
antimicrobial use and the epidemiology
of resistant pneumococci (2). Also in the
hospital setting, lowering the use of spe-
cific antibiotics impacts resistance rates (3,
4). Still, examples of the positive effect
of reduction of antibiotic use on resis-
tance rates are scarce, and reasonable doubt
exists about the possibilities to reverse
resistance once it is established. Antibiotic
resistance comes at a fitness cost, and has
an effect on bacterial growth rate. This
should lead to outgrowth of the suscepti-
ble strains of bacteria when the selective
pressure of antibiotics is reduced. Anders-
son and Hughes reviewed the available data
and conclude that the rate of reversibility is
probably very low, due to the acquisition of
mutations that compensate for the loss of
fitness (5).
Less explored is the effect of low vs.
high antibiotic use on the introduction and
transmission of resistant strains. Possibly,
antibiotic use may affect the ease and rapid-
ity by which resistant strains are transmit-
ted and establish themselves in new hosts.
If this is true, it would mean that low
antibiotic use in a population can help
to resist the introduction and spread of
resistant strains in that population, even
when the pressure for introduction is high.
The Netherlands (and other countries with
low antibiotic use) may serve as a model
for this assumption. The Netherlands has
the lowest human antibiotic consumption
rate of Europe: this was 11.4 defined daily
doses (DDD) per 1000 inhabitants/day in
2011; high antibiotic-consuming countries
used three times as much (32.0 and 35.1
DDD per 1000 inhabitants/day in Cyprus
and Greece, respectively) (6). At the same
time, this country belongs to the large con-
sumers of veterinary antibacterial agents
in Europe: between 2005 and 2009 it
had among the highest sales of antibiotics
for veterinary use of 10 European coun-
tries investigated by Grave et al. (7, 8).
In particular, sales of third- and fourth-
generation veterinary cephalosporins were
high in The Netherlands (8). The effect
of this use was, among others, reflected
in high resistance rates to cephalosporins
in E. coli in broiler chickens (9), and
resulted in high contamination rates of
chicken meat with extended-spectrum
beta-lactamases (ESBL)-producing enter-
obacteriaceae (10). Contamination with
ESBL-producing strains was found in up
to 90% of retail chicken meat samples (10,
11). Another veterinary indicator of high
antibiotic use is the massive colonization
of Dutch pigs with methicillin-resistant
Staphylococcus aureus (MRSA) (12). Resis-
tant strains are also found in the Dutch
soil (13, 14) and on vegetable produce (15,
Reuland et al., submitted for publication).
Taken together, this means that the
Dutch human population lives in an
ecosystem that is brimming with antibiotic
resistant strains, with the large use of
antibiotics in livestock farming. In addi-
tion, resistant strains are continuously
introduced by travelers. Yearly, nearly 15
million outbound holiday trips are booked
by the Dutch; of these,approximately 3 mil-
lion are spent outside Europe (16). These
figures do not include business travel. Ini-
tially, it was thought that resistant strains
are brought to Dutch hospitals mainly by
patients who are repatriated after a stay
in foreign hospitals: a study performed in
2004 showed that nearly one in five patients
coming from foreign hospitals is colonized
with resistant bacteria (17). Now, 10 years
later, several studies have shown that travel
in itself, without hospitalization in the for-
eign country is a risk factor for acquisition
of resistant strains. These recent studies
have focused on bacteria producing ESBL
and carbapenemases. The first study was
a Swedish study that addressed coloniza-
tion of Swedish travelers and showed that
24% of healthy persons who were not colo-
nized with ESBL-producing strains prior to
travel, were colonized upon return (18). A
second study was performed in the Nether-
lands by Paltansing and colleagues (19).
These authors showed that a little less than
one third of travelers become colonized
with ESBL-positive bacteria during travel.
Half of these still carried resistant strains
after 6 months.
Despite the constant presence of resis-
tant strains in their surrounding and
the continuous introduction of resistant
strains through travel, resistance in humans
in The Netherlands is low when compared
to other European countries. This is shown
year after year by the surveillance data
reported annually by EARS-NET (Euro-
pean Antimicrobial Resistance Surveillance
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System of ECDC) (20). Thus, low antibi-
otic use in a population seems to mini-
mize the spread of antimicrobial resistance,
even if this population is embedded in an
antibiotic-rich environment and continu-
ously threatened by introduction of new
resistant strains.
Still, it should be noted that these low
rates of resistance are slowly increasing, and
the rise is a cause of concern. It is as yet
impossible to estimate what the main con-
tributors are. As a result of widespread con-
cern, a movement toward lower antibiotic
use in animal husbandry has been started.
The latest report on monitoring of antimi-
crobial resistance and antibiotic usage in
animals in the Netherlands (21) shows
that total sales of antibiotics for veterinary
use have dropped by approximately 50%
between 2007 and 2012. Among others, the
use of third generation cephalosporins was
completely stopped in March 2010 in broil-
ers and in pigs. This is accompanied by a
reduction in resistance in colonizing E. coli
in chicken, pigs, and calves. The future will
tell whether this change is sufficient to slow
down the rising resistance in humans.
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